Cellular activation through the ligation of intercellular adhesion molecule-1

Area of Science:

• Immunology
• Cell Biology
• Inflammation Research

Background:

• Intercellular adhesion molecule-1 (ICAM-1) is crucial for leukocyte infiltration at inflammatory sites.
• ICAM-1 mediates leukocyte adherence and migration across the endothelium.
• The role of interstitial cell ICAM-1 in controlling leukocyte infiltration requires further elucidation.

Purpose of the Study:

• To investigate the de novo synthesis of ICAM-1 mRNA and protein in response to leukocyte binding.
• To determine the role of ICAM-1-dependent activation in cultured cells.
• To explore the impact of ICAM-1 cross-linking on adhesion molecule expression and intracellular calcium levels.

Main Methods:

• Culturing human renal cortex and lung fibroblasts and endothelial cells.
• Inducing de novo synthesis of ICAM-1 via leukocyte binding and ICAM-1 cross-linking with antibodies.
• Measuring ICAM-1 mRNA and protein expression levels over time.
• Assessing VCAM-1 expression following ICAM-1 cross-linking.
• Monitoring cytosolic free calcium changes using calcium imaging and BAPTA-AM.

Main Results:

• Leukocyte binding and ICAM-1 cross-linking induced de novo synthesis of ICAM-1 mRNA and protein.
• ICAM-1 mRNA levels increased two- to threefold, peaking at 1-3 hours post-cross-linking.
• Peak ICAM-1 protein expression occurred between 18 and 48 hours.
• ICAM-1 cross-linking also led to increased VCAM-1 expression.
• Both leukocyte binding and ICAM-1 cross-linking triggered a rise in cytosolic free calcium, which was essential for adhesion molecule upregulation.

Conclusions:

• Direct cell surface interaction of ICAM-1 with inflammatory cell ligands stimulates endothelial cells and fibroblasts.
• Upregulated synthesis and expression of cellular adhesion molecules is a key phenotypic change.
• These findings suggest significant implications for controlling leukocyte infiltration and the progression of inflammatory diseases.